Polysaccharide-PVA/PEG blended Crosslinked Hybrid Hydrogels for Cardiac Tissue Engineering
Keywords:
cardiac tissue engineering, hybrid hydrogels, biocompatibility, regenerative cardiology, polymeric blendAbstract
As the native ECM exists as hydrogel, biocompatible polymeric hydrogel-based templates promise tissue engineering applications owing to their biomimetic nature. Hence, the choice of co-polymers employed is crucial in determining the cardiac performance of such hydrogels. On this juncture, the present study aimed to engineer biocompatible hybrid hydrogel scaffolds by the interpenetration and crosslinking of the natural polymers with synthetic polymers for cardiac regeneration. Two sets of hydrogels ACPVs (alginate, carboxy methyl cellulose and PVA as components) and ASPGs (Alginate, starch, and PEG as components) were prepared. FT-IR revealed the ample hydrophilic surface functional groups, water dynamics unveiled appreciable water holding capacity
befitting native cardiac ECM, SEM analysis displayed surface porosity and dynamic contact angle unveiled the amphiphilic chemistry. The hydrogels were biodegradable as evaluated by aging in simulated biological fluids and the cytocompatibility was assessed with MTT cell viability assay and direct contact assay using H9c2 cardiomyoblasts. The hydrogel supported the growth and survival of H9c2 cardiomyoblasts onto the interstices. Also, the hydrogels were effective in imbibing antibiotics and arrested the growth of major Gram-positive and Gram-negative bacteria. Overall, the findings demonstrated that the reinforced hydrogel system exhibits optimum
physicochemical properties, excellent biocompatibility, and appreciable biological performance to support cardiac cell growth suggesting the promising translational avenues in regenerative cardiology.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Soumya K. Chandrasekhar, Joshi C. Ouseph (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.


